Timeline

Voting rights breakdown

Notice details

Beneficial owner

Federated Hermes, Inc

The shareholding of the Federated Hermes Kaufmann Fund has exceeded 5% and now holds: 269,289 ADRs and 1,348,708 common shares, equivalent to 5.03% of the voting rights in Molecular Partners AG. The Federated Hermes Kaufmann Small Cap Fund now holds: 125,364 ADRs and 1,109,359 common shares, equivalent to 3.84% of the voting rights in Molecular Partners AG. We herewith confirm we meet and will continue to meet the independence requirements as stipulated in art. 18 para. 3 and 5 FMIO-FINMA.